Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma

Abstract

Metastasis rate increased significantly with increasing primary tumor dimensions at time of patient enrollment. Prognosis after metastatic disease remains poor. Effective methods are needed to prevent, diagnose, and treat metastasis from choroidal melanoma.